Drugs / GSK1674330A
last change Oct 2008 re-read 2 minutes ago

GSK1674330A

Developed for
human papilloma virus infection
Investigated by
GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00478621 May 2007 → Jun 2008 human papilloma virus infection GlaxoSmithKline Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as GSK1674330A ClinicalTrials.gov intervention name — accepted as the source's own label NCT00478621